HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of a homozygous one-basepair deletion in exon 14 of the LAMB3 gene in a patient with Herlitz junctional epidermolysis bullosa and prenatal diagnosis in a family at risk for recurrence.

Abstract
Herlitz junctional epidermolysis bullosa, a severe epidermal blistering disorder, is inherited in an autosomal recessive manner. It has recently been shown that, in kindreds with junctional epidermolysis bullosa, the disorder results from mutations in the gamma 2 chain of laminin-5, a basement membrane protein synthesized by the basal cells of stratifying squamous epithelia. In this report we describe a mutation identified in the beta 3 chain gene of laminin-5 in a family with Herlitz junctional epidermolysis bullosa. The disease is caused by a homozygous deletion of 1 bp that leads to a frameshift and premature termination codon. The segregation of the mutated allele in the family is consistent with the pathogenic role of the mutation. We also report a direct DNA-based prenatal exclusion of Herlitz junctional epidermolysis bullosa in a pregnancy at risk using a chorionic villus biopsy and allele-specific oligomer hybridization from polymerase chain reaction-amplified genomic DNA.
AuthorsJ Vailly, L Pulkkinen, C Miquel, A M Christiano, D Gerecke, R E Burgeson, J Uitto, J P Ortonne, G Meneguzzi
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 104 Issue 4 Pg. 462-6 (Apr 1995) ISSN: 0022-202X [Print] United States
PMID7706759 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Laminin
Topics
  • Base Sequence
  • Epidermolysis Bullosa, Junctional (diagnosis, genetics)
  • Exons
  • Female
  • Frameshift Mutation
  • Gene Deletion
  • Homozygote
  • Humans
  • Laminin (genetics)
  • Molecular Sequence Data
  • Pregnancy
  • Prenatal Diagnosis
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: